Only indication is in the therapy of C. difficile colitis, particularly recurrent or severe disease
Tier 2 Protected Antimicrobial
Strategies Used:
GI side effects
Bile acid sequestrants may diminish therapeutic effect
Antimicrobial class: Glycopeptide
Pregnancy category: B
Average serum half life: 0 hours
Urine penetration: None
Lung penetration: None
CSF penetration: None
Biliary penetration: None
Firvanq
No oral absorption.
May increase vancomycin resistant Enterococci colonization in the gut.